Products
525 products
| Code | Description | Unit |
|---|---|---|
| SAF-PHR1295-1.2ML | Ethylene oxide stock solution, pharmaceutical secondard standard, traceable to PhEur | 1,2 mL |
| SAF-PHR1824-50MG | (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazoleStatus 4 | 50 mg |
| SAF-PHR1461-1G | Copper ChlorophyllinStatus 4 | 1 g |
| SAF-PHR1804-500MG | Paroxetine for system suitability (EP)Status 4 | 500 mg |
| SAF-PHR1414-1G | Methyl StearateStatus 4 | 1 g |
| SAF-PHR1571-1G | (Z)-9-Octadecenoic acid methyl ester (Oleic acid methyl ester)Status 4 | 1 g |
| SAF-PHR1827-500MG | MoxidectinStatus 4 | 500 mg |
| SAF-PHR1797-1G | Imipramine HydrochlorideStatus 4 | 1 g |
| SAF-PHR1726-40MG | 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfon amideStatus 4 | 40 mg |
| SAF-PHR1772-500MG | Meropenem trihydrateStatus 4 | 500 mg |
| SAF-PHR1812-500MG | Tranexamic AcidStatus 4 | 500 mg |
| SAF-PHR1783-500MG | AnastrozoleStatus 4 | 500 mg |
| SAF-PHR1539-2X6.5MG | Insulin (Pork)Status 4 | 2 x 6,5 mg |
| SAF-PHR1440-1G | Hydroxypropyl BetadexStatus 4 | 1 g |
| SAF-PHR1784-500MG | AripiprazoleStatus 4 | 500 mg |
| SAF-PHR1821-50MG | 16aIpha,17 -[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4, 14-triene-3,20-dioneStatus 4 | 50 mg |
| SAF-PHR1637-1G | Benztropine MesylateStatus 4 | 1 g |
| SAF-PHR1825-1G | OlanzapineStatus 4 | 1 g |
| SAF-PHR1806-500MG | RifampicinStatus 4 | 500 mg |
| SAF-PHR1814-50MG | Glipizide impurity D - 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamideStatus 4 | 50 mg |
| SAF-PHR1801-500MG | Minocycline Hydrochloride (HCl)Status 4 | 500 mg |
| SAF-PHR1822-50MG | 16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dioneStatus 4 | 50 mg |
| SAF-PHR1516-200MG | Glycyrrhizic AcidStatus 4 | 200 mg |
| SAF-PHR1490-1ML | Monoethanolamine | 1 mL |
| SAF-PHR1792-1G | Fluphenazine DihydrochlorideStatus 4 | 1 g |
| SAF-PHR1754-30MG | 1-(3-Chlorophenyl)-2-hydroxy-1-propanoneStatus 4 | 30 mg |
| SAF-PHR1645-1G | Sodium Iron EDTAStatus 4 | 1 g |
| SAF-PHR1622-3ML | TravoprostStatus 4 | 3 mL |
| SAF-PHR1798-250MG | Levamisol hydrochlorideStatus 4 | 250 mg |
| SAF-PHR1810-500MG | TadalafilStatus 4 | 500 mg |
| SAF-PHR1807-500MG | Sildenafil-citrateStatus 4 | 500 mg |
| SAF-PHR1820-100MG | 2,4,diamino-7-hydroxy-6-phenylpteridineStatus 4 | 100 mg |
| SAF-PHR1819-100MG | 2,7-Diamino-4-hydroxy-6-phenylpteridineStatus 4 | 100 mg |
| SAF-PHR1781-500MG | Oseltamivir Phosphate | 500 mg |
| SAF-PHR1771-300MG | Digoxin | 300 mg |
| SAF-PHR1780-1G | Betamethasone 17a-valerate | 1 g |
| SAF-PHR1823-50MG | 16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione | 50 mg |
| SAF-PHR1778-1G | Tolnaftate | 1 g |
| SAF-PHR1818-1G | Glimepiride Sulfonamide | 1 g |
| SAF-PHR1816-100MG | 4-Chloro-5-sulfamoylanthranilic Acid | 100 mg |
| SAF-PHR1628-1G | Dexamethasone Phosphate | 1 g |
| SAF-PHR1803-200MG | Paclitaxel | 200 mg |
| SAF-PHR1813-50MG | 4-[beta-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide | 50 mg |
| SAF-PHR1538-250MG | Pseudoephedrine Hydrochloride | 250 mg |
| SAF-PHR1832-200MG | Fenbendazole | 200 mg |
| SAF-PHR1802-300MG | Naloxone | 300 mg |
| SAF-PHR1777-1G | Orphenadrine Citrate | 1 g |
| SAF-PHR1475-1G | Disodium Inosinate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1828-500MG | 1,8-Cineol (Eucalyptol) | 500 mg |
| SAF-PHR1326-5G | Calcium Carbonate, pharmaceutical secondary standard, traceable to USP | 5 g |
| SAF-PHR1188-3X100MG | Isotretinoin, pharmaceutical secondary standard, traceable to USP and PhEur | 3 x 100 mg |
| SAF-PHR1389-1G | Propyphenazone, pharmaceutical secondary standard, traceable to PhEur | 1 g |
| SAF-PHR1267-1G | Ethyl Maltol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1795-100MG | 10,11-Dihydro-5H-dibenzo[b,f]azepine | 100 mg |
| SAF-PHR1246-500MG | Fenofibrate, pharmaceutical secondary standard, traceable to USP and PhEur | 500 mg |
| SAF-PHR1526-1G | Dexamethasone, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 1 g |
| SAF-PHR1606-1G | Hydrocortisone 21-Acetate, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 1 g |
| SAF-PHR1238-500MG | Vitamin D2, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 500 mg |
| SAF-PHR1014-500MG | Amount of cortisol in the ampoule, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 500 mg |
| SAF-PHR1043-500MG | Prednisolone, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 500 mg |
| SAF-PHR1770-500MG | Lycopene, pharmaceutical secondary standard, traceable to USP | 500 mg |
| SAF-PHR1770-5X100MG | Lycopene, pharmaceutical secondary standard, traceable to USP | 3 x 100 mg |
| SAF-PHR1353-1G | 17-beta-Estradiol, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1575-500MG | Propantheline Bromide | 500 mg |
| SAF-PHR1368-100MG | 2,3-Dichlorobenzoic acid, pharmaceutical secondary standard, traceable to USP and PhEur | 100 mg |
| SAF-PHR1750-1G | Reserpine, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1258-1G | Chloroquine diphosphate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1532-200MG | Metformin impurity F - Dimethylamine hydrochloride, pharmaceutical secondary standard, traceable to PhEur | 200 mg |
| SAF-PHR1627-100MG | Vecuronium Bromide, pharmaceutical secondary standard, traceable to USP, PhEur | 100 mg |
| SAF-PHR1006-1G | D-Glucitol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1003-1G | Acetylsalicylic acid, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1008-2G | Ascorbic acid (Vitamin C), pharmaceutical secondary standard, traceable to USP, PhEur and BP | 2 g |
| SAF-PHR1000-1G | D-(+)-Glucose, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1053-1G | Albuterol Sulfate, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1499-500MG | Flurbiprofen, pharmaceutical secondary standard, traceable to USP, PhEur | 500 mg |
| SAF-PHR1215-3X1.5ML | Lactic acid, pharmaceutical secondary standard, traceable to USP | 3 x 1,5 mL |
| SAF-PHR1227-500MG | Fluorouracil, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 500 mg |
| SAF-PHR1826-20MG | 1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole | 20 mg |
| SAF-PHR1509-500MG | Adrenaline Tartrate, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 500 mg |
| SAF-PHR1075-1G | Cimetidine, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1613-1G | Levothyroxine, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1183-500MG | (2-chlorophenyl)(phenyl)methanone, pharmaceutical secondary standard, traceable to PhEur | 500 mg |
| SAF-PHR1705-1G | Mefloquine Hydrochloride, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1745-500MG | 4-Aminophenol hydrochloride, pharmaceutical secondary standard, traceable to USP | 500 mg |
| SAF-PHR1336-1G | Nimesulide, pharmaceutical secondary standard, traceable to PhEur | 1 g |
| SAF-PHR1511-500MG | Carbachol, pharmaceutical secondary standard | 500 mg |
| SAF-PHR1693-50MG | Pyridoxine impurity A - 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol, pharmaceutical secondary standard, traceable to PhEur | 50 mg |
| SAF-PHR1794-500MG | Hesperidin | 500 mg |
| SAF-PHR1582-1G | Dehydroacetic Acid, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1630-1G | Acetic Acid 2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl Ester, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 1 g |
| SAF-PHR1300-500MG | Dequalinium chloride, pharmaceutical secondary standard, traceable to PhEur | 500 mg |
| SAF-PHR1658-1G | Dimenhydrinate, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1515-1G | Copper Gluconate | 1 g |
| SAF-PHR1724-400MG | Haloperidol | 400 mg |
| SAF-PHR1042-1G | 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1535-500MG | Estrone, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 500 mg |
| SAF-PHR1715-1G | Sisomicin Sulfate, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1395-1G | Methocarbamol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1231-1G | Benzoic acid-sodium salt, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1337-1G | Thiamine mononitrate, pharmaceutical secondary standard, traceable to PhEur and BP | 1 g |